Medical Automation Market Size, Share & Trends Analysis Report By Application Type (Therapeutic Automation, Laboratory & Pharmacy Automation), By End -use (Hospitals & Diagnostic Centers, Pharmacies), By Region, And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within 3 Business Days
Medical Automation Market Growth & Trends
The global medical automation market size is anticipated treach USD 88.11 billion by 2030, according ta new report by Grand View Research, Inc. The market is projected tgrow at a CAGR of 9.26% from 2025 t2030. This is attributed tthe rapid technological advancements in lab and pharmacy automation, as well as diagnostic and monitoring automation, which are generating global demand for healthcare automation. Increased government involvement is expected tdrive the global healthcare automation market over the forecast period.
Healthcare automation provides cutting-edge solutions in hospital pharmacy automation, logistics and transport, and material handling applications. Healthcare automation is being invested in by labs and research facilities all around the world tsimplify various processes and increase overall work productivity. This automation is helping research institutes leverage overall productivity in healthcare facilities, improve experimental data quality, and reduce lab process cycle times, as a result, increasing automation adoption by pharmacies, labs, and research centers is expected tdrive market growth over the forecast period.
Furthermore, the rising prevalence of chronic illnesses, as well as the increasing implementation of automated diagnostic and therapeutic equipment, are driving market expansion. According tthe World Health Organization (WHO), chronic illnesses are one of the main causes of death in the world, with cancer, stroke, heart disease, diabetes, and respiratory disorders accounting for roughly 60% of all fatalities. Furthermore, according tNCBI, by 2030, around 40.5% of the US population is expected thave one or more cardiovascular disorders, expanding the customer base for this industry.
Market players adopt strategies such as collaborations, launches, and mergers & acquisitions tstrengthen their industry position. For instance, in June 2022, GE Healthcare collaborated with Medtronic taccelerate global access tpersonalized care by offering an advanced patient monitoring system on the CARESCAPE platform. This collaboration enabled GE Healthcare tadvance patient care, improve decision-making, boost healthcare system efficiency, and link caregivers & their patients within an ecosystem
Medical Automation Market Report Highlights
Medical Automation Market Growth & Trends
The global medical automation market size is anticipated treach USD 88.11 billion by 2030, according ta new report by Grand View Research, Inc. The market is projected tgrow at a CAGR of 9.26% from 2025 t2030. This is attributed tthe rapid technological advancements in lab and pharmacy automation, as well as diagnostic and monitoring automation, which are generating global demand for healthcare automation. Increased government involvement is expected tdrive the global healthcare automation market over the forecast period.
Healthcare automation provides cutting-edge solutions in hospital pharmacy automation, logistics and transport, and material handling applications. Healthcare automation is being invested in by labs and research facilities all around the world tsimplify various processes and increase overall work productivity. This automation is helping research institutes leverage overall productivity in healthcare facilities, improve experimental data quality, and reduce lab process cycle times, as a result, increasing automation adoption by pharmacies, labs, and research centers is expected tdrive market growth over the forecast period.
Furthermore, the rising prevalence of chronic illnesses, as well as the increasing implementation of automated diagnostic and therapeutic equipment, are driving market expansion. According tthe World Health Organization (WHO), chronic illnesses are one of the main causes of death in the world, with cancer, stroke, heart disease, diabetes, and respiratory disorders accounting for roughly 60% of all fatalities. Furthermore, according tNCBI, by 2030, around 40.5% of the US population is expected thave one or more cardiovascular disorders, expanding the customer base for this industry.
Market players adopt strategies such as collaborations, launches, and mergers & acquisitions tstrengthen their industry position. For instance, in June 2022, GE Healthcare collaborated with Medtronic taccelerate global access tpersonalized care by offering an advanced patient monitoring system on the CARESCAPE platform. This collaboration enabled GE Healthcare tadvance patient care, improve decision-making, boost healthcare system efficiency, and link caregivers & their patients within an ecosystem
Medical Automation Market Report Highlights
- The medical automation market was valued at USD 52.09 Billion in 2024 and is expected tgrow at a CAGR of 9.26% during the forecast period.
- Based on the Application, the therapeutic automation market segment held the largest share of over 53.60%, and it is alsexpected tbe the fastest-growing segment over the forecast period. This is due tthe rising number of solutions on the market and initiatives undertaken by leading companies.
- The laboratory and pharmacy automation market is estimated tattain the highest CAGR of 11.51% from 2024 t2030. This is due tthe growing need for automation in labs and pharmacies, as well as the tremendous potential for disease identification and treatment. On the other hand, the medical software, informatics, and logistics automation market is expected tgrow at the fastest rate over the forecast period.
- Based on end-use, hospitals & diagnostic centers held the largest revenue share of the market in 2024. It is alsprojected texpand at the fastest CAGR during the forecast period, owing tthe increasing use of automated equipment in hospitals & diagnosis, and other treatment centers. On the other hand, the research laboratories & institutes segment accounted for a market share of over 48.11% in 2024.
- North America and Europe are likely tbe the primary growth regions for this market. Emerging markets such as Asia Pacific are likely tsee positive development throughout the forecast period as healthcare infrastructure improves and increasing demand for automation in healthcare systems
- A common trend observed is an increase in market participant collaboration for innovation through using each other's capabilities. For instance, Danaher Corporation launched its new Biomek NGeniuS Next Gen Library Preparation System. This initiative will speed up next-generation sequencing and make it more accessible tresearch laboratories of all sizes.
- In addition, a competitive environment permits significant R&D investments, distribution agreements, and contracts, which are anticipated tmaintain industry competition over the forecast period. For instance, in April 2022, Philips and Prisma Health signed a multiyear strategic agreement toffer healthcare system advancements. Philips will be able textend its advanced medical care tbetter patient outcomes and the future of healthcare owing tthe long-term strategic collaboration.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Application Type Segment
1.2.2. End Use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective
1.10.2. Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
CHAPTER 3. MEDICAL AUTOMATION MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Technology advancements
3.2.1.2. Governments supporting medical automation innovations with funding
3.2.1.3. Rising demand for robotic surgery
3.2.1.4. Increasing adoption of automation in healthcare system
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of automation
3.2.2.2. Lack of skilled professionals
3.3. Medical Automation Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political Landscape
3.3.2.2. Technological Landscape
3.3.2.3. Economic Landscape
3.3.2.4. Environmental Landscape
3.3.2.5. Legal Landscape
3.3.2.6. Social Landscape
3.3.3. Regulatory Framework
3.3.4. Emerging Technologies Trends
3.3.5. Case Study & Insights
3.3.5.1. Use Cases
3.3.5.2. Related Survey
3.3.6. COVID-19 Impact Analysis
CHAPTER 4. MEDICAL AUTOMATION MARKET: APPLICATION TYPE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Global Medical Automation Market Application Type Movement Analysis
4.3. Global Medical Automation Management Market Size & Trend Analysis, by Application Type, 2018 - 2030 (USD Million)
4.4. Imaging Automation Market
4.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.2. Integrated Image Analysis software systems
4.4.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.3. Medical Intraoperative Imaging
4.4.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.3.2. iCT
4.4.3.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.3.3. iUltrasound
4.4.3.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.3.4. iMRI
4.4.3.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.3.5. C-arm system
4.4.3.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5. Therapeutic Automation Market
4.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.2. Non-Surgical Automation Market
4.5.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.2.2. Defibrillators
4.5.2.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.2.2.2. Implantable Cardioverter Defibrillators
4.5.2.2.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.2.2.3. Automated External (Portable) Defibrillators
4.5.2.2.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.2.2.4. Wearable cardioverter defibrillators
4.5.2.2.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.2.3. Electronic Drug Delivery Systems
4.5.2.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.3. Surgical Automation Market
4.5.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.3.2. Surgical Robotic device
4.5.3.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.3.3. Intelligent Operating Rooms
4.5.3.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.3.4. Surgical Simulators
4.5.3.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.6. Laboratory and Pharmacy Automation Market
4.6.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.6.2. Laboratory Automation
4.6.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.6.2.2. Total Automation (Inclusive of Pre-analysis, Transport Mechanisms, Liquid Handling, Sample Storage, & Analysis)
4.6.2.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.6.2.3. Modular Automation Systems (Inclusive of Specimen Acquisition & Identification & Labelling, Transport Mechanisms, Sample Preparation, Sample Loading & Aspiration, Reagent Handling & Storage, Sample Analysis & Measurements)
4.6.2.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.6.3. Pharmacy Automation
4.6.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.7. Medical Software, Informatics, and Logistics Automation Market
4.7.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.7.2. Software and Informatics
4.7.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.7.3. Logistics Automation
4.7.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 5. MEDICAL AUTOMATION MARKET: END USE ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Global Medical Automation Market End Use Movement Analysis
5.3. Global Medical Automation Market Size & Trend Analysis, by End Use, 2018 - 2030 (USD Million)
5.4. Hospitals & Diagnostic Centers
5.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
5.5. Research Laboratories & Institutes
5.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
5.6. Pharmacies
5.6.1. Market estimates and forecasts 2018 - 2030 (USD Million)
5.7. Others (Home/Ambulatory Care Settings, etc.)
5.7.1. Market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 6. MEDICAL AUTOMATION MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Market Size, & Forecasts Trend Analysis, 2018 - 2030:
6.4. North America
6.4.1. U.S.
6.4.1.1. Key country dynamics
6.4.1.2. Regulatory framework/ reimbursement structure
6.4.1.3. Competitive scenario
6.4.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
6.4.2. Canada
6.4.2.1. Key country dynamics
6.4.2.2. Regulatory framework/ reimbursement structure
6.4.2.3. Competitive scenario
6.4.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
6.4.3. Mexico
6.4.3.1. Key country dynamics
6.4.3.2. Regulatory framework/ reimbursement structure
6.4.3.3. Competitive scenario
6.4.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
6.5. Europe
6.5.1. UK
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
6.5.2. Germany
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
6.5.3. France
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
6.5.4. Italy
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/ reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
6.5.5. Spain
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/ reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
6.5.6. Norway
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/ reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
6.5.7. Sweden
6.5.7.1. Key country dynamics
6.5.7.2. Regulatory framework/ reimbursement structure
6.5.7.3. Competitive scenario
6.5.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
6.5.8. Denmark
6.5.8.1. Key country dynamics
6.5.8.2. Regulatory framework/ reimbursement structure
6.5.8.3. Competitive scenario
6.5.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Japan
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
6.6.2. China
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
6.6.3. India
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
6.6.4. Australia
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework/ reimbursement structure
6.6.4.3. Competitive scenario
6.6.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
6.6.5. South Korea
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework/ reimbursement structure
6.6.5.3. Competitive scenario
6.6.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
6.6.6. Thailand
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework/ reimbursement structure
6.6.6.3. Competitive scenario
6.6.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
6.7. Latin America
6.7.1. Brazil
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
6.7.2. Argentina
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
6.8. MEA
6.8.1. South Africa
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework/ reimbursement structure
6.8.1.3. Competitive scenario
6.8.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
6.8.2. Saudi Arabia
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework/ reimbursement structure
6.8.2.3. Competitive scenario
6.8.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
6.8.3. UAE
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework/ reimbursement structure
6.8.3.3. Competitive scenario
6.8.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
6.8.4. Kuwait
6.8.4.1. Key country dynamics
6.8.4.2. Regulatory framework/ reimbursement structure
6.8.4.3. Competitive scenario
6.8.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Company/Competition Categorization
7.2. Company Market Position Analysis, 2023
7.3. Company Profiles/Listing
7.3.1. Accuray Incorporated
7.3.1.1. Company overview
7.3.1.2. Financial performance
7.3.1.3. Product benchmarking
7.3.1.4. Strategic initiatives
7.3.2. Tecan Trading AG
7.3.2.1. Company overview
7.3.2.2. Financial performance
7.3.2.3. Product benchmarking
7.3.2.4. Strategic initiatives
7.3.3. Medtronic
7.3.3.1. Company overview
7.3.3.2. Financial performance
7.3.3.3. Product benchmarking
7.3.3.4. Strategic initiatives
7.3.4. Swisslog Holding AG
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. GE Healthcare
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Intuitive Surgical Operations, Inc.
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Stryker
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Siemens
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Koninklijke Philips N.V.
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Danaher Corporation
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Zimmer Biomet
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Application Type Segment
1.2.2. End Use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective
1.10.2. Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
CHAPTER 3. MEDICAL AUTOMATION MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Technology advancements
3.2.1.2. Governments supporting medical automation innovations with funding
3.2.1.3. Rising demand for robotic surgery
3.2.1.4. Increasing adoption of automation in healthcare system
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of automation
3.2.2.2. Lack of skilled professionals
3.3. Medical Automation Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political Landscape
3.3.2.2. Technological Landscape
3.3.2.3. Economic Landscape
3.3.2.4. Environmental Landscape
3.3.2.5. Legal Landscape
3.3.2.6. Social Landscape
3.3.3. Regulatory Framework
3.3.4. Emerging Technologies Trends
3.3.5. Case Study & Insights
3.3.5.1. Use Cases
3.3.5.2. Related Survey
3.3.6. COVID-19 Impact Analysis
CHAPTER 4. MEDICAL AUTOMATION MARKET: APPLICATION TYPE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Global Medical Automation Market Application Type Movement Analysis
4.3. Global Medical Automation Management Market Size & Trend Analysis, by Application Type, 2018 - 2030 (USD Million)
4.4. Imaging Automation Market
4.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.2. Integrated Image Analysis software systems
4.4.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.3. Medical Intraoperative Imaging
4.4.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.3.2. iCT
4.4.3.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.3.3. iUltrasound
4.4.3.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.3.4. iMRI
4.4.3.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.3.5. C-arm system
4.4.3.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5. Therapeutic Automation Market
4.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.2. Non-Surgical Automation Market
4.5.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.2.2. Defibrillators
4.5.2.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.2.2.2. Implantable Cardioverter Defibrillators
4.5.2.2.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.2.2.3. Automated External (Portable) Defibrillators
4.5.2.2.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.2.2.4. Wearable cardioverter defibrillators
4.5.2.2.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.2.3. Electronic Drug Delivery Systems
4.5.2.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.3. Surgical Automation Market
4.5.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.3.2. Surgical Robotic device
4.5.3.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.3.3. Intelligent Operating Rooms
4.5.3.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.3.4. Surgical Simulators
4.5.3.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.6. Laboratory and Pharmacy Automation Market
4.6.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.6.2. Laboratory Automation
4.6.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.6.2.2. Total Automation (Inclusive of Pre-analysis, Transport Mechanisms, Liquid Handling, Sample Storage, & Analysis)
4.6.2.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.6.2.3. Modular Automation Systems (Inclusive of Specimen Acquisition & Identification & Labelling, Transport Mechanisms, Sample Preparation, Sample Loading & Aspiration, Reagent Handling & Storage, Sample Analysis & Measurements)
4.6.2.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.6.3. Pharmacy Automation
4.6.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.7. Medical Software, Informatics, and Logistics Automation Market
4.7.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.7.2. Software and Informatics
4.7.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.7.3. Logistics Automation
4.7.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 5. MEDICAL AUTOMATION MARKET: END USE ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Global Medical Automation Market End Use Movement Analysis
5.3. Global Medical Automation Market Size & Trend Analysis, by End Use, 2018 - 2030 (USD Million)
5.4. Hospitals & Diagnostic Centers
5.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
5.5. Research Laboratories & Institutes
5.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
5.6. Pharmacies
5.6.1. Market estimates and forecasts 2018 - 2030 (USD Million)
5.7. Others (Home/Ambulatory Care Settings, etc.)
5.7.1. Market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 6. MEDICAL AUTOMATION MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Market Size, & Forecasts Trend Analysis, 2018 - 2030:
6.4. North America
6.4.1. U.S.
6.4.1.1. Key country dynamics
6.4.1.2. Regulatory framework/ reimbursement structure
6.4.1.3. Competitive scenario
6.4.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
6.4.2. Canada
6.4.2.1. Key country dynamics
6.4.2.2. Regulatory framework/ reimbursement structure
6.4.2.3. Competitive scenario
6.4.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
6.4.3. Mexico
6.4.3.1. Key country dynamics
6.4.3.2. Regulatory framework/ reimbursement structure
6.4.3.3. Competitive scenario
6.4.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
6.5. Europe
6.5.1. UK
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
6.5.2. Germany
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
6.5.3. France
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
6.5.4. Italy
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/ reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
6.5.5. Spain
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/ reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
6.5.6. Norway
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/ reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
6.5.7. Sweden
6.5.7.1. Key country dynamics
6.5.7.2. Regulatory framework/ reimbursement structure
6.5.7.3. Competitive scenario
6.5.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
6.5.8. Denmark
6.5.8.1. Key country dynamics
6.5.8.2. Regulatory framework/ reimbursement structure
6.5.8.3. Competitive scenario
6.5.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Japan
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
6.6.2. China
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
6.6.3. India
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
6.6.4. Australia
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework/ reimbursement structure
6.6.4.3. Competitive scenario
6.6.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
6.6.5. South Korea
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework/ reimbursement structure
6.6.5.3. Competitive scenario
6.6.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
6.6.6. Thailand
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework/ reimbursement structure
6.6.6.3. Competitive scenario
6.6.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
6.7. Latin America
6.7.1. Brazil
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
6.7.2. Argentina
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
6.8. MEA
6.8.1. South Africa
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework/ reimbursement structure
6.8.1.3. Competitive scenario
6.8.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
6.8.2. Saudi Arabia
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework/ reimbursement structure
6.8.2.3. Competitive scenario
6.8.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
6.8.3. UAE
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework/ reimbursement structure
6.8.3.3. Competitive scenario
6.8.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
6.8.4. Kuwait
6.8.4.1. Key country dynamics
6.8.4.2. Regulatory framework/ reimbursement structure
6.8.4.3. Competitive scenario
6.8.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Company/Competition Categorization
7.2. Company Market Position Analysis, 2023
7.3. Company Profiles/Listing
7.3.1. Accuray Incorporated
7.3.1.1. Company overview
7.3.1.2. Financial performance
7.3.1.3. Product benchmarking
7.3.1.4. Strategic initiatives
7.3.2. Tecan Trading AG
7.3.2.1. Company overview
7.3.2.2. Financial performance
7.3.2.3. Product benchmarking
7.3.2.4. Strategic initiatives
7.3.3. Medtronic
7.3.3.1. Company overview
7.3.3.2. Financial performance
7.3.3.3. Product benchmarking
7.3.3.4. Strategic initiatives
7.3.4. Swisslog Holding AG
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. GE Healthcare
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Intuitive Surgical Operations, Inc.
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Stryker
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Siemens
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Koninklijke Philips N.V.
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Danaher Corporation
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Zimmer Biomet
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
